View More Recent Stories

Apr 24, 2018 04:05PM Jazz Pharmaceuticals to Report 2018 First Quarter Financial Results on May 8, 2018
Mar 6, 2018 04:05PM Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March
Mar 2, 2018 08:30AM Jazz Pharmaceuticals (JAZZ) Announces FDA Acceptance of NDA for Solriamfetol
Mar 2, 2018 08:30AM Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Feb 27, 2018 04:05PM Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2017 Financial Results
Feb 23, 2018 08:31AM Jazz Pharmaceuticals (JAZZ) Reports 1st Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide
Feb 23, 2018 08:30AM Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of Acute Graft-versus-Host Disease
Feb 13, 2018 04:05PM Jazz Pharmaceuticals to Report 2017 Fourth Quarter and Full Year Financial Results on February 27, 2018
Feb 8, 2018 05:08PM Jazz Pharmaceuticals (JAZZ) Reports Addition of Vyxeos (daunorubicin & cytarabine) Liposome for Injection by National Comprehensive Cancer Network to Clinical Practice Guidelines in Oncology
Feb 8, 2018 04:15PM National Comprehensive Cancer Network® adds Jazz Pharmaceuticals' Vyxeos™ (daunorubicin and cytarabine) Liposome for Injection to Clinical Practice Guidelines in Oncology
Dec 21, 2017 08:31AM Jazz Pharmaceuticals (JAZZ) Submits NDA for Solriamfetol for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
Dec 21, 2017 08:30AM Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
Jul 28, 2016 04:08PM Jazz Pharma (JAZZ), Pfenex (PFNX) Enter Hematological Malignancies-Related Licensing Agreement
Jul 28, 2016 04:05PM Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies
Jul 28, 2016 04:05PM Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies
Apr 13, 2016 09:33AM Pre-Open Stock Movers 04/13: (RPRX) (ACUR) (MDVN) Higher; (CLVS) (VRX) (S) Lower (more...)
Mar 30, 2016 12:24PM Streetinsider.com's Hot Lunchtime Reads 3/30: (MET) (JAZZ) (VRX) (TWTR)
View More Recent Stories